In patients with COPD, pro-inflammatory cytokines, like tumor necrosis factor (TNF)α, can activate the NF-κB signaling to increase inflammatory cytokine production and inducible nitric oxide synthase (iNOS) expression. Here, NFKB1 is linked to chronic obstructive pulmonary disease.